Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v6-FR
Language French French
Date Updated 2020-12-03 2020-12-03
Drug Identification Number 02470462 02470462
Brand name GENTAMICIN INJECTION USP GENTAMICIN INJECTION USP
Common or Proper name Gentamicin Gentamicin
Company Name HIKMA CANADA LIMITED HIKMA CANADA LIMITED
Ingredients GENTAMICIN GENTAMICIN
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 2 mL 2 mL
ATC code J01GB J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2020-11-09 2020-11-09
Actual start date
Estimated end date 2020-11-30 2020-11-30
Actual end date 2020-12-01 2020-12-01
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments